v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 26,035 $ 13,091
Cost of revenue:    
Total cost of revenue 11,578 6,702
Gross profit 14,457 6,389
Operating expenses:    
Research and development 13,017 8,302
Selling, general and administrative 13,787 6,640
Total operating expenses 26,804 14,942
Loss from operations (12,347) (8,553)
Interest income, net 539 786
Interest expense (223) (46)
Loss on remeasurement of convertible notes (8,594)  
Other (expense) income, net (236) 154
Net loss before income tax (20,861) (7,659)
Provision for income taxes 464  
Net loss $ (21,325) $ (7,659)
Net loss per share, basic $ (1.74) $ (0.68)
Net loss per share, diluted $ (1.74) $ (0.68)
Weighted-average common shares outstanding, basic 12,259,811 11,258,870
Weighted-average common shares outstanding, diluted 12,259,811 11,258,870
Product Revenue    
Revenue:    
Total revenue $ 21,341 $ 9,169
Cost of revenue:    
Total cost of revenue 9,810 5,371
Service and Other Revenue    
Revenue:    
Total revenue 4,694 3,922
Cost of revenue:    
Total cost of revenue $ 1,768 $ 1,331